Laxai Pharma, Ltd. (LAXAF)
Laxai Pharma, Ltd. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Tampa, FL, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $475,341. Its beta of 2.45 implies it has historically moved more than the broad market.
Laxai Pharma, Ltd. is an American company that offers specialized contract research services. The firm provides extensive support throughout the entire pharmaceutical development process. Its areas of expertise include biostatistics, various data management methodologies (such as electronic, hybrid, and paper-based systems), CDISC advisory, medical documentation, clinical trial monitoring, regulatory compliance, pharmacovigilance, and associated training initiatives. The company, which was initially named Nexgen Biofuels Ltd., officially adopted the name Laxai Pharma, Ltd. in February 2010. Its headquarters are located in Tampa, Florida.
Laxai Pharma, Ltd. is most often compared with the following Healthcare names: